Abstract

BackgroundPatients with polyarticular Juvenile Idiopathic Arthritis (JIA) suffer from functional impairments caused by inflammation [1]. While medical treatment leads to an improvement of disease activity in JIA [2], little is...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Correlation between Peptidyl Arginine Deiminase Type 4 Polymorphism and Disease Activity in Polyarticular Juvenile Idiopathic Arthritis in Egyptian Patients
...
The Egyptian Journal of Hospital Medicine | VOL. 72
, et. al. ...
01 Jul 2018
Correlation between Peptidyl Arginine Deiminase Type 4 Polymorphism and Disease Activity in Polyarticular Juvenile Idiopathic Arthritis in Egyptian Patients
...
The Egyptian Journal of Hospital Medicine | VOL. 72
, et. al. ...
01 Jul 2018
21 Disease activity and body mass index in juvenile idiopathic arthritis: is the truth revealed?
...
Rheumatology | VOL. 61
, et. al. ...
07 Oct 2022
Low Level of Vitamin D is Correlated with High C-Reactive Protein (CRP) and Disease Activity in Indonesian Juvenile Idiopathic Arthritis (JIA) Patients
Desy Wulandari ... Wisnu Barlianto
The Indonesian Biomedical Journal | VOL. 12
Desy Wulandari, et. al.Desy Wulandari ... Wisnu Barlianto
29 Jun 2020
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers